Contents

Current Pharmaceutical Design, Volume 13 - Number 5

Editorial [ Hot Topic: Novel Targets for Cancer Therapy (Executive Editor: E. Bergmann-Leitner) ]

, 13(5): 445 - 446

E. Bergmann-Leitner


DOI: 10.2174/138161207780162881




NF-κB Signaling and Carcinogenesis

, 13(5): 447 - 462

Takashi Okamoto, Takaomi Sanda and Kaori Asamitsu


DOI: 10.2174/138161207780162944




Targeting Different Signaling Pathways with Antisense Oligonucleotides Combination for Cancer Therapy

, 13(5): 463 - 470

C. Leonetti and G. Zupi


DOI: 10.2174/138161207780162917




Proteasome as an Emerging Therapeutic Target in Cancer

, 13(5): 471 - 485

I. Zavrski, L. Kleeberg, M. Kaiser, C. Fleissner, U. Heider, J. Sterz, C. Jakob and O. Sezer


DOI: 10.2174/138161207780162908




Novel Therapeutic Approaches Based on the Targeting of Microenvironment-Derived Survival Pathways in Human Cancer: Experimental Models and Translational Issues

, 13(5): 487 - 496

Pierfrancesco Tassone, Pierosandro Tagliaferri, Maria Teresa Fulciniti, Maria Teresa Di Martino and Salvatore Venuta


DOI: 10.2174/138161207780162872




Targeted Therapy of Breast Cancer

, 13(5): 497 - 517

Raffaele Longo, Francesco Torino and Giampietro Gasparini


DOI: 10.2174/138161207780162890




Current Concepts for the Combined Treatment Modality of Ionizing Radiation with Anticancer Agents

, 13(5): 519 - 535

Christoph Oehler, Daniel J. Dickinson, Angela Broggini-Tenzer, Barbara Hofstetter, Andreas Hollenstein, Oliver Riesterer, Van Vuong and Martin Pruschy


DOI: 10.2174/138161207780162935




Towards the Development of Tumor Necrosis Factor (TNF) Sensitizers:Making TNF Work Against Cancer

, 13(5): 537 - 551

Simone Mocellin, Pierluigi Pilati and Donato Nitti


DOI: 10.2174/138161207780162926




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science